ABI-H3733

N/A

Report date: 2025/03/19 14:54:49
NME

Base Information

Drug NameABI-H3733
Drug Alias NameABI-H3733
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis B virus capsid protein inhibitors
TargetsHepatitis B virus capsid protein
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaSingaporeRomania +[7] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAssembly Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAssembly Biosciences IncBeOne Medicines Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A